Skip to main content
. 2022 Feb 1;9:823900. doi: 10.3389/fmed.2022.823900

Figure 3.

Figure 3

Forest plots representing the odds ratio for using biologics in the multivariate analysis for the global (A), CD (B), and UC (C) cohorts of patients. (D) Survival analysis of the time to first biologic drug in immigrant vs. native patients. CD, Crohn's disease; UC, ulcerative colitis.